BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24628824)

  • 1. Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention.
    Hodgson JM; Metcalfe SA; Aitken M; Donath SM; Gaff CL; Winship IM; Delatycki MB; Skene LL; McClaren BJ; Paul JL; Halliday JL
    BMC Med Genet; 2014 Mar; 15():33. PubMed ID: 24628824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of a randomised controlled trial of a complex genetic counselling intervention to improve family communication.
    Hodgson J; Metcalfe S; Gaff C; Donath S; Delatycki MB; Winship I; Skene L; Aitken M; Halliday J
    Eur J Hum Genet; 2016 Mar; 24(3):356-60. PubMed ID: 26130486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; van Tintelen JP; Smets EMA; Christiaans I
    BMJ Open; 2019 Jul; 9(7):e025660. PubMed ID: 31289060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
    Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
    Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating a custom-designed aid to improve communication of genetic results in families with hypertrophic cardiomyopathy: study protocol for a randomised controlled trial.
    Burns C; Yeates L; Semsarian C; Ingles J
    BMJ Open; 2019 Feb; 9(1):e026627. PubMed ID: 30782759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
    de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
    Trials; 2014 Mar; 15():86. PubMed ID: 24649895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalising genetic counselling (POETIC) trial: Protocol for a hybrid type II effectiveness-implementation randomised clinical trial of a patient screening tool to improve patient empowerment after cancer genetic counselling.
    Forrest LE; Tutty E; De Silva AP; Petelin L; Ruscigno A; Purvis R; Monohan K; Kentwell M; Sexton A; Stafford L; James PA
    Trials; 2023 Nov; 24(1):712. PubMed ID: 37941026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proband-mediated interventions to increase disclosure of genetic risk in families with a BRCA or Lynch syndrome condition: a systematic review.
    Young AL; Imran A; Spoelma MJ; Williams R; Tucker KM; Halliday J; Forrest LE; Wakefield CE; Butow PN
    Eur J Hum Genet; 2023 Jan; 31(1):18-34. PubMed ID: 36253533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; Baars MJH; van Tintelen JP; Smets EMA; Christiaans I
    Eur J Hum Genet; 2022 Feb; 30(2):203-210. PubMed ID: 34815540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased genetic counseling support improves communication of genetic information in families.
    Forrest LE; Burke J; Bacic S; Amor DJ
    Genet Med; 2008 Mar; 10(3):167-72. PubMed ID: 18344705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery.
    Shickh S; Hirjikaka D; Clausen M; Kodida R; Mighton C; Reble E; Sam J; Panchal S; Aronson M; Graham T; Armel SR; Glogowski E; Elser C; Eisen A; Carroll JC; Shuman C; Seto E; Baxter NN; Scheer A; Shastri-Estrada S; Feldman G; Thorpe KE; Schrader KA; Lerner-Ellis J; Kim RH; Faghfoury H; Bombard Y
    BMJ Open; 2022 Apr; 12(4):e060899. PubMed ID: 35487723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AMBER care bundle for hospital inpatients with uncertain recovery nearing the end of life: the ImproveCare feasibility cluster RCT.
    Koffman J; Yorganci E; Murtagh F; Yi D; Gao W; Barclay S; Pickles A; Higginson I; Johnson H; Wilson R; Bailey S; Ewart C; Evans C
    Health Technol Assess; 2019 Oct; 23(55):1-150. PubMed ID: 31594555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics.
    Derbez B; de Pauw A; Stoppa-Lyonnet D; de Montgolfier S
    Fam Cancer; 2017 Jul; 16(3):447-457. PubMed ID: 28293859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of genetic services with and without genetic registers: knowledge, adjustment, and attitudes about genetic counselling among probands referred to three genetic clinics.
    Wright C; Kerzin-Storrar L; Williamson PR; Fryer A; Njindou A; Quarrell O; Donnai D; Craufurd D
    J Med Genet; 2002 Dec; 39(12):e84. PubMed ID: 12471222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct contact in inviting high-risk members of hereditary colon cancer families to genetic counselling and DNA testing.
    Aktan-Collan K; Haukkala A; Pylvänäinen K; Järvinen HJ; Aaltonen LA; Peltomäki P; Rantanen E; Kääriäinen H; Mecklin JP
    J Med Genet; 2007 Nov; 44(11):732-8. PubMed ID: 17630403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial.
    Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA
    Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.